Singapore Government Banning E-Cigarettes for Public Health Reasons

Regulations by 2FIRSTS.ai
Jan.11.2024
Singapore Government Banning E-Cigarettes for Public Health Reasons
Singapore Deputy Prime Minister Lawrence Wong stated that the ban on e-cigarettes in 2018 was due to public health concerns, not potential tax losses.

Deputy Prime Minister of Singapore, Lawrence Wong, stated that the ban on e-cigarettes in 2018 was driven by public health concerns, rather than worries over potential tax losses. This response comes in regard to Professor James Lim's questioning of whether the prohibition on e-cigarettes was motivated by potential tax revenue losses.

 

In a written response, Huang Xuncai stated that the purpose of the ban is to protect Singaporeans from the harms of e-cigarettes. He emphasized that potential tobacco tax revenue loss did not play a role in this decision.

 

In response to Professor Lin's proposal to legalize and tax e-cigarettes, Huang Xuncai stated that if the government chooses to legalize e-cigarettes and impose taxes, it will face similar challenges as with tobacco products. However, he emphasized that the government has no plans to change its current approach because the primary concern is to protect public health, especially that of young people.

 

In Singapore, e-cigarettes are currently illegal, and offenders may face fines of up to SGD 2,000 (approximately USD 1,480). The government has announced heightened scrutiny on e-cigarettes, including inspections at borders, business districts, shopping malls, and other public places, as well as monitoring illegal sales. Those found in violation of the ban may be subject to fines and potential imprisonment.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Charlie’s Holdings Signs Licensing Agreement with IKE Tech to Commercialize Age-Gated Vape Technology in the U.S.
Charlie’s Holdings Signs Licensing Agreement with IKE Tech to Commercialize Age-Gated Vape Technology in the U.S.
Charlie’s Holdings has signed a licensing agreement with IKE Tech to commercialize an age-gated vape activation system in the U.S. The technology combines biometric authentication, BLE hardware, and a mobile app for continuous device-level age verification. The company plans to test-market the system with SBX nicotine analogue products this spring and may later apply it to PACHA-branded ENDS.
News
Jan.06
Kardinal to Launch Dual Open-System Devices Globally in Q1 2026
Kardinal to Launch Dual Open-System Devices Globally in Q1 2026
Kardinal OS and Syn Signal Strategic Expansion in Open-System ENDS
Dec.31
Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%
Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%
Imperial Brands reported FY25 NGP net revenue of £368 million, up 13.7% at constant currency. Growth in the Americas accelerated sharply, with NGP revenue up 69.8%, driven by the expansion of the modern oral brand Zone. Europe delivered 8.8% growth, supported by blu’s double-digit vapour share across key markets. Adjusted NGP operating losses narrowed to £76 million, putting the category closer to breakeven.
Nov.18 by 2FIRSTS.ai
Irish Cabinet to Consider Bill Banning Sale of Single-Use Vapes
Irish Cabinet to Consider Bill Banning Sale of Single-Use Vapes
Ireland’s Minister for Health, Jennifer Carroll MacNeill, will seek Cabinet approval today for the publication of the Public Health (Single-Use Vapes) Bill 2025, which proposes banning the retail sale of single-use or disposable vapes six months after becoming law. The measure aims to address the growing use of disposable vapes, particularly among young people, and close regulatory gaps around emerging nicotine products such as pouches.
Nov.18 by 2FIRSTS.ai
2FIRSTS Data Insight|China’s Vape Exports to the U.S. Hit a Record $590 Million: A Peak Driven by Enforcement Cycles, Not Real Demand
2FIRSTS Data Insight|China’s Vape Exports to the U.S. Hit a Record $590 Million: A Peak Driven by Enforcement Cycles, Not Real Demand
China’s vape exports to the U.S. surged to a record $590 million in October 2025—nearly double the usual monthly level and pushing the U.S. share above 50% of China’s global shipments.But the spike was not driven by demand. Instead, it reflected a temporary release created by tightened U.S. enforcement, a collapsed logistics pathway, and a bullwhip-style surge in replenishment.The peak signals more volatility ahead, not recovery.
Special Report
Nov.24
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai